PTSD Study

If you’re struggling with PTSD, with or without medication, you could participate in this research study of an investigational PTSD drug.

A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole as Monotherapy or as combination therapy in the treatment of adults with Post-traumatic Stress Disorder

Age 18-65

Onset of PTSD symptoms for a minimum of 6 months and no longer than 15 years

Initial onset after the age of 16

Not currently receiving Zoloft

  • * Required Field

    Submission of this form does not guarantee your enrollment in any study, but it does let us know you have an interest in participating.

  • This field is for validation purposes and should be left unchanged.